Articles

Gildeuretinol halts Stargardt disease progression, study results indicate

The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases

Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President

The tissue serves as a testing ground for outpatient ocular therapies

The 15th annual Congress on Controversies in Ophthalmology heads to Athens, Greece

Lohith Shetty will lead marketing for the company, based in Kleinostheim, Germany

I-SCREEN will bring together 12 institutions across Europe, including Queen’s University Belfast

Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting

Lourens van Zyl wanted to set himself apart in a highly competitive surrounding and saw a potential for practice building by offering solutions for presbyopia in patients without cataract. Within a few years this group became a significant segment of his practice in total share. ZEISS PRESBYOND was the game changer for a business success story.

Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation

Three IOLs are evaluated in a randomised study

Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages

The UK's Royal National Institute of Blind People is the global distributor of the headset and ARxVision is partnering with the National Federation of the Blind and Vision Australia to expand global accessibility

Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period

An AI-supported telemedicine effort from Siloam Vision and Orbis International

In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407

The opportunities and challenges presented by CRISPR manipulation

The European Commission is expected to make a decision about the application before the end of June

Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs

Diabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.

Proteins common to Alzheimer disease play a significant role in glaucoma

Quantitative and qualitative improvement in IOL design

Researchers investigated patients' ability to drive and work following eye injury

A case study emphasises the shifting paradigm in clinical best practices

Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease

Research indicates smoking increases risk of AMD, cataracts and glaucoma

Kiora also stated a Phase 2 trial of KIO-104 is expected to begin later this year

Investigators emphasised that the data does not indicate a causal relationship between the eye disorder and systemic diseases